Pfizer (PFE.N)and partner BioNTech (22UAy.DE) plan to ask U.S. and European regulators within weeks to authorize a booster dose of its COVID-19 vaccine, based on evidence of greater risk of infection six months after inoculation and the spread of the highly contagious Delta variant. The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and...
Category: Tech
Post
Post
Twitter Blue membership administration dispatches in Australia and Canada
Twitter is dispatching its new participation organization, Twitter Blue, in Australia and Canada on Thursday. The paid-for extra help will add features, for instance, an “fix tweet” catch, bookmarks, and a peruser mode, Twitter said. The confined dispatch is proposed to “gain a more significant understanding” of what customers are looking for. However, the association...
Post
AstraZeneca, Smurfit Kappa boost FTSE 100 higher
London’s FTSE 100 edged higher on Friday, boosted by earnings updates from AstraZeneca and Smurfit Kappa, while optimism around a speedy recovery from pandemic-led crash set the blue-chip index for its biggest monthly gain since November 2020. The FTSE 100 index rose 0.4%, with AstraZeneca gaining 2.6% after it forecast higher sales in the second...
Post
BioNTech co-founder says he’s confident that vaccine works against Indian variant
BioNTech co-founder Ugur Sahin voices confidence that the vaccine his company jointly developed with Pfizer works against the Indian variant of the coronavirus. “We are still testing the Indian variant, but the Indian variant has mutations that we have already tested for and which our vaccine works against, so I am confident,” says Sahin. “The...
Post
German State Signs Agreement For Sputnik Purchase Pending Regulatory Approval
The German state of Bavaria has signed an agreement to buy 2.5 million doses of Russia’s Sputnik V coronavirus vaccine once it is approved by European regulators. Markus Soeder, the premier of the southeastern German state, said on April 7 that Bavaria signed a memorandum of understanding for the supply of Sputnik V. If the...
Post
Washington appoints envoy to administer vaccines, pledges to increase its aid
US Secretary of State Anthony Blinken confirmed that his country will soon be able to increase its international aid for vaccines against Covid-19 and will not seek “in return for concessions,” announcing the appointment of a veteran official as the US coordinator for the global response to the virus. Blinken told reporters that the top...
Post
AstraZeneca says COVID19 vaccine 76% effective in the new analysis, to seek U.S. approval
AstraZeneca’s said its COVID-19 vaccine was 76% effective in a new analysis of its U.S. trial – only a tad lower than the level in an earlier report this week criticised for using outdated data. Interim data published on Monday had put the vaccine’s efficacy rate at 79% but had not included more recent infections,...
Post
WHO approves Oxford-AstraZeneca Covid-19 vaccine for emergency use
The World Health Organization (WHO) on Monday listed AstraZeneca and Oxford University’s COVID-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the developing world. A WHO statement said it had approved the vaccine as produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India. “We now have all the pieces in place for...
Post
China has approved the use of the second locally developed vaccine against COVID19
France-Press Agency reported that the authorities responsible for the pharmaceutical sector in China have given a “conditional green light” to use the second vaccine against COVID-19 developed in the country, called “Corona Vacc”, which was developed by Sinovac, as announced today by the pharmaceutical industries company. “The approval for the use of the vaccine comes...
Post
China approves Sinovac Biotech COVID19 vaccine for general public use
Sinovac Biotech said on Saturday that its unit’s COVID-19 vaccine has been formally approved for use by the general public by China’s medical products regulator. Prior to the approval, the CoronaVac vaccine had already been administered in China’s vaccination programme mainly targeting key groups deemed to be at higher risk of exposure to the virus....